NZM2:ETR
Novozymes A/S
€58.00
0.00%
(0.00) 1D
Okt 13, 5:35:34 PM GMT+2 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa NZM2...
Mkt. cap
180.58B
Avg. na dami
120.00
Dami
0.00
Mataas nang 52-wk
€61.96
Mababa nang 52-wk
€46.74
Bilang ng mga empleyado
11K
Mkt. cap
180.58B
Avg. na dami
120.00
Dami
0.00
Mataas nang 52-wk
€61.96
Mababa nang 52-wk
€46.74
Bilang ng mga empleyado
11K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Bloomberg.com
·
16 oras ang nakalipas
S&P 500 Record Rally Meets Risk of Peaking Earnings Growth
Investopedia
·
9 oras ang nakalipas
Jeff Bezos Aims for the Moon But Advises Retirees to Stick With Index Funds
Reuters
·
1 buwan ang nakalipas
S&P 500 to end 2026 slightly above current levels on profit optimism
CNBC
·
1 buwan ang nakalipas
The biggest U.S. stocks have done great for you. Experts say not to get greedy
Profile
Novonesis is a biotechnology company headquartered in Lyngby, Denmark. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen.
The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy.
The merger, first announced in December 2022, was the largest merger in history between two Danish companies. It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations.
The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings A/S, which is owned by the Novo Nordisk Foundation.
As of 2025, Novonesis has more than 11,000 employees and activities in over 45 countries. Wikipedia
Tungkol sa Novozymes A/S
CEOEster Baiget
Mga Empleyado11.1K
Itinatag2000
Headquarters-
SektorSpeciality chemicals
Websitenovonesis.com